Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients
- 31 December 1994
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 4 (4) , 241-246
- https://doi.org/10.1016/0924-8579(94)90024-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virusAntimicrobial Agents and Chemotherapy, 1992
- AcyclovirDrugs, 1989
- Lack of effect of acyclovir on postherpetic neuralgia.BMJ, 1989
- Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cellsAntimicrobial Agents and Chemotherapy, 1989
- A sharper Bonferroni procedure for multiple tests of significanceBiometrika, 1988
- Some biological properties of BRL 42810, a well absorbed oral prodrug of the antiherpesvirus agent BRL 39123 : M.R. Boyd, R. Boon, S.E. Fowles, K. Pagano, D. Sutton, R.A. Vere Hodge and B.D. Zussman. Beecham Pharmaceuticals, Research Division, Great Burgh, Epsom, Surrey, United KingdomAntiviral Research, 1988
- Varicella-Zoster Virus InfectionsAnnals of Internal Medicine, 1988
- Acute herpetic and postherpetic neuralgia: Clinical review and current managementAnnals of Neurology, 1986
- Herpes zoster and postherpetic neuralgiaPain, 1986
- Population-Based Study of Herpes Zoster and Its SequelaeMedicine, 1982